Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement

Cited by (535)

Items 501–535 of 535

1. Broadly neutralizing antibodies against emerging delta-coronaviruses
   Megi Rexhepaj, Young‐Jun Park, Lisa Perruzza, Daniel E. Asarnow, Matthew McCallum, Katja Culap, Christian Saliba, Giada Leoni, Alessio Balmelli, Courtney N. Yoshiyama et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
2. Analysis the molecular similarity of least common amino acid sites in ACE2 receptor to predict the potential susceptible species for SARS-CoV-2
   YeZhi Hu, Xin Fan, Arivizhivendhan Kannan Villalan, Shuang Zhang, Fekede Regassa, XiaoDong Wu, Haoning Wang, XiaoLong Wang · 2024 · PLoS ONE
3. Computational Study on Repurposing G-Quadruplex Ligands Against the Main Protease of Sars-Cov-2 Variants
   Napat Prompat, Varomyalin Tipmanee, Panik Nadee, Amornrat Phongdara, Aekkaraj Nualla‐ong · 2024 · SSRN Electronic Journal
4. Variability in SARS-CoV-2 Spike Protein Sequences: Impact on Receptor Binding and Immunotherapeutic Strategies
   Aqsa Riaz, Irshad Ur Rehman, Jamshaid Ahmad, Amin Ullah, Saeed Ullah Khattak, Dalal Sulaiman Alshaya, Eman Fayad, Refaat Ali Eid, Muhammad Alaa Eldeen · 2024 · Journal of Computational Biophysics and Chemistry
5. Molecular docking and molecular dynamics simulation studies reveal repurposing I-Motif ligand as a promising protease inhibitor against SARS-CoV-2 variants
   Napat Prompat, Panik Nadee, Amornrat Phongdara, Aekkaraj Nualla‐ong · 2024 · Molecular Simulation
6. Distinct Binding Modes of Inter-Spike Cross-Linking Suggest a Supplementary Mechanism for SARS-CoV-2 Antibody Neutralization
   Xuanyu Nan, Yujie Li, Rui Zhang, Ruoke Wang, Niannian Lv, Jiayi Li, Yuanfang Chen, Bini Zhou, Yangjunqi Wang, Ziyi Wang et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
7. In vitro to clinical efficacy: Neutralizing antibodies against severe acute respiratory syndrome coronavirus 2 strains
   Masaki Kakimoto, Toshihito Nomura, Tanuza Nazmul, Akima Yamamoto, Kotaro Ikeda, Daisuke Miyamori, Akifumi Higashiura, Yuki Kaiki, Hiroki Kitagawa, Keitaro Omori et al. · 2024 · Journal of Infection and Chemotherapy
8. Isolation and Preliminary Characterization of a Novel scFv against SARS-CoV-2 : an Experimental and Computational Analysis
   Samaneh Jahandar-Lashaki, Safar Farajnia, Effat Alizadeh, Farzin Seirafi, Asghar Tanoumand, Mohammad Kazem Hosseini · 2025 · Avicenna Journal of Medical Biotechnology
9. Within-Host Fitness and Antigenicity Shift Are Key Factors Influencing the Prevalence of Within-Host Variations in the SARS-CoV-2 S Gene
   Binbin Xi, Zhihao Hua, Dawei Jiang, Zixi Chen, Jinfen Wei, Yu-Huan Meng, Hongli Du · 2025 · Viruses
10. Exploring Diverse Binding Mechanisms of Broadly Neutralizing Antibodies S309, S304, CYFN-1006 and VIR-7229 Targeting SARS-CoV-2 Spike Omicron Variants: Integrative Computational Modeling Reveals Balance of Evolutionary and Dynamic Adaptability in Shaping Molecular Determinants of Immune Escape
    Mohammed Alshahrani, Vedant Parikh, Brandon Foley, Gennady M. Verkhivker · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
11. Conformational Landscaping and Dynamic Mutational Profiling of Binding Interactions and Immune Escape for Broadly Neutralizing Class I Antibodies with SARS-CoV-2 Spike Protein: Distributed Binding Hotspot Networks Underlie Mechanism of Viral Resistance Against Existing Variants
    Mohammed Alshahrani, Vedant Parikh, Brandon Foley, Gennady M. Verkhivker · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
12. Exploring Dynamic Modulation of Binding, Allostery and Immune Resistance in the SARS-CoV-2 Spike Complexes with Classes of Antibodies Targeting Cryptic Binding Sites: Antibody-Specific Augmentations of Conserved Allosteric Architecture Can Influence Evolution of Viral Escape
    Mohammed Alshahrani, Vedant Parikh, Brandon Foley, Gennady M. Verkhivker · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
13. Deciphering the Mechanistic Continuum of Broadly Neutralizing Class 4 Antibodies Targeting Conserved Cryptic Epitopes of the SARS-CoV-2 Spike Protein : Operating at the Intersection of Binding, Allostery and Immune Escape
    Mohammed Alshahrani, Vedant Parikh, Brandon Foley, Gennady M. Verkhivker · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
14. Breakthrough SARS-CoV-2 outcomes in immune-disordered people during the Omicron era: a prospective cohort study
    Mackenzie Zendt, Fausto Andres Bustos Carrillo, Viviane Callier, Maureen DeGrange, Anita Ginigeme, Lurline Wu, Bevin Manuelpillai, Ana Maria Ortega‐Villa, Emily Ricotta · 2025 · BMJ Public Health
15. ADAPT-M: a workflow for rapid, quantitative in vitro measurements of enriched protein libraries
    Carla P. Perez, Nicole V. DelRosso, Cameron L. Noland, Udit Parekh, Christian A. Choe, Raphael R. Eguchi, Qi Wen, Polly Morrell Fordyce, Po‐Ssu Huang · 2026 · Nature Communications
16. On campus dormitories as viral transmission sinks: Phylodynamic insights into student housing networks during the COVID-19 pandemic
    Juan Bolanos, Alex Dornburg, April Harris, Samuel Kunkleman, Jannatul Ferdous, William Taylor, Jessica Ann Schlueter, Cynthia Gibas · 2025 · PLoS Pathogens
17. A SARS-CoV-2 entry inhibitor trimerizes to lock the spike protein in a closed conformation
    Huihui Mou, Bo Gao, Gang Ye, Lizhou Zhang, Divyasha Saxena, Fan Bu, Jyoti Vishwakarma, Shuo Zhou, Claudia Ruiz Bayona, Li Lin et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
18. Identification of a novel dual-targeting peptide inhibitor of SARS-CoV-2 RBD and NRP1 through structure-based virtual screening
    Nan Yao, Lixia Guan, Li Feng, Gang Wang, Yuting Wang, Miaomiao Niu, Mei Yu, Shengnan Yin · 2025 · Frontiers in Pharmacology
19. Additional file 1 of A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants
    Lee, I-Jung, Sun, Cheng-Pu, Wu, Ping-Yi, Lan, Yu-Hua, Wang, I-Hsuan, Liu, Wen-Chun, Joyce Pei‐Yi Yuan, Chang, Yu-Wei, Tseng, Sheng-Che, Tsung, Szu-I et al. · 2022 · Figshare
20. Additional file 1 of A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies
    Monika Kumari, Lu, Ruei-Min, Li, Mu-Chun, Jhih‐Liang Huang, Hsu, Fu-Fei, Ko, Shih-Han, Ke, Feng-Yi, Su, Shih-Chieh, Liang, Kang-Hao, Joyce Pei‐Yi Yuan et al. · 2022 · Figshare
21. SARS-CoV-2 peptide fragments selectively dysregulate specific immune cell populations via Gaussian curvature targeting
    Yue Zhang, Carlos Silvestre-Roig, Han Fu, Haleh Alimohamadi, Taraknath Mandal, Jonathan W. Chen, Elizabeth Wei-Chia Luo, Jaime de Anda, Anna Lívia Linard Matos, Mathis Richter et al. · 2026 · Proceedings of the National Academy of Sciences
22. Mapping spatial colleague connectivity patterns from individual-level registry data to inform regional pandemic interventions
    PingPing Song, Sake J. de Vlas, Tom Emery, Luc Edgar Coffeng · 2026 · PLoS Computational Biology
23. Mutation-driven adaptation of ACE2–RBD binding revealed by integrative molecular dynamics analysis
    Linh Truong Hoai, Baso Ilham, Thanakorn Sompornpisut, Muhammad Luthfi, R. B. Pandey, Pornthep Sompornpisut · 2026 · Journal of Molecular Graphics and Modelling
24. Bibliometric and Descriptive Analysis of SARS-CoV-2 Immune Escape Using Bioinformatics Approaches (2020–2025)
    Maha Ouarab, Zineb Rhazzar, Nadia Touil, Elmostafa El Fahime · 2026 · COVID
25. Frustration Landscapes of Broadly Neutralizing SARS-CoV-2 Spike Antibodies Targeting Conserved Epitopes Reveal Energetic Logic of Escape-Proof and Escape-Prone Mechanisms
    Mohammed Alshahrani, Will Gatlin, Max Ludwick, Lucas Turano, Brandon Foley, Gennady M. Verkhivker · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
26. SARS-CoV-2 and neurological disorders
    Marija Zivaljic · 2022 · theses.fr (ABES)
27. Étude de la réponse humorale lors de l'infection par le SARS-CoV-2
    Stéphane Marot · 2023 · theses.fr (ABES)
28. Point Substitution N33D in the Light Chain of Neutralizing Antibody REGN10987 Increases the Fab Affinity to RBD of Omicron BA.1 SARS-CoV-2 Variant. In Silico Study
    D. Nolde, M. Kocharovskaya, A. Popov, M. Kirpichnikov, E. N. Lyukmanova, Z. Shenkarev · 2026 · Russian journal of bioorganic chemistry
29. Glycan shielding and epitope reorganization drive sotrovimab resistance in SARS-CoV-2 Omicron variants
    Ankit Kumar, Amar Jeet Yadav, Timir Tripathi, Aditya Kumar Padhi · 2026 · Archives of Biochemistry and Biophysics
30. Mitigation of imprinted antibody responses against COVID-19 in highly vaccinated older adults
    Rebecca B. Morse, Daniel J.S. Egan, Mark Tsz Kin Cheng, Mazharul Altaf, Kimia Kamelian, Claire Gallagher, Lourdes Ceron‐Gutierrez, Olga Sokolova, John R. Bradley, Kenneth G. C. Smith et al. · 2026 · Journal of Infection
31. From weak but broad to potent and universal: A trispecific antibody against conserved SARS-CoV-2 spike epitopes
    Xiaodong Tian, Chunmei Wang, Pu Han, Honghui Liu, Lili Wu, Xiaoyun Wang, Shufan Yu, Yanning zhang, Binbin Zhao, Jiangning Liu et al. · 2026 · Molecular Therapy
32. The His41 site of 3CLpro is a new target for designing broad-spectrum antiviral agents against coronaviruses via a non-covalent pan-binding mode
    Dongbo Sun, Xiaoxu Xing, Li Li, Jiongze Cheng, Haixin Liu, Bin Xu, Xin Yin, Jun Wang, Feiyu Zhao, Jiawei Xiao et al. · 2026 · Research Square
33. Contrasting dynamic and mechanistic signatures of Class 3 and Class 4 neutralizing antibodies targeting SARS-CoV-2 spike protein: dissecting molecular determinants of neutralization mechanisms using a multi-pronged computational approach
    Mohammed Alshahrani, Will Gatlin, Max Ludwick, Lucas Turano, Brandon Foley, Gennady M. Verkhivker · 2026 · Physical Chemistry Chemical Physics
34. Proteolytic control of the SARS-CoV-2 furin cleavage site defines the phenotypic evolution from the pandemic to endemic state
    Anupriya Aggarwal, Samantha Ognenovska, Timothy Ison, Christina Fichter, Vanessa Milogiannakis, Madeeha Afzal, Alberto Ospina-Stella, Daniel Asarnow, Angelica L. Morgan, Shafagh A. Waters et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
35. Antibody-mediated allosteric effects and conserved vulnerabilities of SARS-CoV-2 spike protein revealed by hydrogen/deuterium exchange mass spectrometry
    Qinyu Jia, Chengxi Liu, Chang Zhao, Zhong‐Ping Yao · 2026 · Acta Pharmaceutica Sinica B